BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19695901)

  • 21. Experimental evaluation of early and long-term effects of microparticle embolization in two different mini-pig models. Part II: liver.
    Stampfl S; Stampfl U; Rehnitz C; Schnabel P; Satzl S; Christoph P; Henn C; Thomas F; Richter GM
    Cardiovasc Intervent Radiol; 2007; 30(3):462-8. PubMed ID: 17342551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged local persistence of cisplatin-loaded gelatin microspheres and their chemoembolic anti-cancer effect in rabbits.
    Ohta S; Nitta N; Sonoda A; Seko A; Tanaka T; Takahashi M; Takemura S; Tabata Y; Murata K
    Eur J Radiol; 2009 Dec; 72(3):534-40. PubMed ID: 18778907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of transarterial embolization with arsenic trioxide oil emulsion in a rabbit VX2 liver tumor model.
    Kim HJ; Shin JH; Kim TH; Kim EY; Park YS; Park CS; Song HY
    J Vasc Interv Radiol; 2009 Oct; 20(10):1365-70. PubMed ID: 19713126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of preoperative transcatheter arterial embolization for improved survival rates in patients with hepatocellular carcinomas (sandwich therapy using ethiodized oil, cisplatin and gelatin sponge].
    Shibata T; Sasaki Y; Imaoka S; Yasuda T; Wada H; Ishikawa O; Ohigashi H; Fukuda I; Kabuto T; Hiratsuka M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2514-9. PubMed ID: 2843115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
    Lu W; Li YH; Yu ZJ; He XF; Chen Y; Zhao JB; Zhu ZY
    Hepatogastroenterology; 2007; 54(77):1499-502. PubMed ID: 17708284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of blood dynamics of anticancer drugs (cisplatin, mitomycin C, epirubicin) in treatment groups of hepatic arterial infusion, hepatic arterial infusion with lipiodol and transcatheter arterial chemoembolization with lipiodol plus gelatin sponge particles in a swine model.
    Ikoma A; Kawai N; Sato M; Minamiguchi H; Nakai M; Nakata K; Tanaka T; Sonomura T
    Hepatol Res; 2012 Dec; 42(12):1227-35. PubMed ID: 22607607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Plasma platinum concentration and anti-tumor effects after intra-arterial infusion of lipiodol-CDDP suspension evaluation with VX 2 rabbit liver cancer model and 7.0 Tesla MRI system].
    Sonoda A; Nitta N; Ohta S; Itoh R; Takahashi M; Murata K; Morikawa S; Inubushi T; Miyagawa Y; Takamori M; Oonaka Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):951-7. PubMed ID: 16835486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo evaluation of cisplatin-loaded superabsorbent polymer microspheres for use in chemoembolization of VX2 liver tumors.
    Maeda N; Osuga K; Shimazu K; Morii E; Mikami K; Hori S; Nakazawa T; Higashihara H; Tomoda K; Nakamura H; Tomiyama N
    J Vasc Interv Radiol; 2012 Mar; 23(3):397-404.e1. PubMed ID: 22209264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
    Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
    Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amifostine (Ethyol) as modulator of hepatic and biliary toxicity from intraarterial hepatic chemoembolization: results of a phase I study.
    Fiorentini G; Giovanis P; Leoni M; De Giorgi U; Cariello A; Dazzi C; Caldeo A
    Hepatogastroenterology; 2001; 48(38):313-6. PubMed ID: 11379297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preliminary study on prefabricated urethra in expander capsule].
    Li P; Li Z; Cai M; Zhan S; Shi B; Jin H; Wang S; Wang Q; Xu L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Oct; 23(10):1212-5. PubMed ID: 19957842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraarterial injection therapy of newly developed cisplatin-phosphatidyl choline-lipiodol suspension for hepatocellular carcinoma.
    Isomoto I; Aikawa H; Mori H; Matsunaga N; Ajimu A; Fukuda T; Ogasawara M
    Radiat Med; 1992; 10(1):19-25. PubMed ID: 1374923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Arterial lipiodol chemoembolization of a left liver metastasis through the right internal thoracic artery].
    Mignon F; Mesurolle B; Qanadli SD; Sissakian JF; Bruckert F; Barré O; Lacombe P
    J Radiol; 1999 Aug; 80(8):872-4. PubMed ID: 10470620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical efficacy of hepatic artery infusion chemotherapy and chemoembolization in the treatment of liver metastases].
    Zeng X; Wang S; Wei C
    Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):365-7. PubMed ID: 9387277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study.
    Baur M; Walter R; Gebauer A; Tscholakoff D; Lochs H; Mühlbacher F; Turetschek K; Binder R; Hudec M; Gangl A; Ferenci P; Dittrich C
    Int J Oncol; 2003 Sep; 23(3):811-9. PubMed ID: 12888922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence factors in hepatic artery infusion chemotherapy and embolization of liver metastases from alimentary tract cancer].
    Li H; Zeng H; Yang L
    Zhonghua Gan Zang Bing Za Zhi; 1999 Sep; 7(3):142-3. PubMed ID: 10572679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infusion chemotherapy and chemoembolization of liver metastases from cancer of the alimentary tract].
    Zeng H; Li H; Shi Z
    Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):422-4. PubMed ID: 11778283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental study of hepatic artery embolization: evaluation of various embolic materials.
    Yamashita Y; Takahashi M; Fukushima S; Nishida M; Nakano M
    Radiat Med; 1987; 5(3):75-82. PubMed ID: 2827239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anticancer and side effect of arterial subsegmental chemoembolization using cisplatinum/pirarubicin lipiodol suspension (CTLS) for hepatocellular carcinoma].
    Inoue H; Miyazono N; Kanetsuki I; Hori A; Tanaka D; Fukukura Y; Matsumoto Y; Nishida H; Ueno K; Nakajo M
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):1973-6. PubMed ID: 7692822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model.
    Namur J; Wassef M; Millot JM; Lewis AL; Manfait M; Laurent A
    J Vasc Interv Radiol; 2010 Feb; 21(2):259-67. PubMed ID: 20123210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.